Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Do these things indoors and out to keep your home cool in summer heat
Recommended
5 On Your Side shares 7 simple ways to cut down your energy bill this summer
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
223.19
-3.41 (-1.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
38
39
Next >
12 Analysts Have This to Say About Biogen
April 11, 2023
Via
Benzinga
3 Biotech Stocks to Watch for Potential Breakthroughs
April 11, 2023
These biotech stocks have significant upside and realistic breakthrough chances in the current and distant future.
Via
InvestorPlace
Twitter Inc Is Officially Defunct, Alibaba Plans to Integrate ChatGPT Like Chatbot Across Products, Moderna's Flu Shot Study Misses 'Early Success' Criteria: Today's Top Stories
April 11, 2023
Benzinga Twitter Inc Is Officially Defunct As Elon Musk Pursues' Superapp' Goal
Via
Benzinga
Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension
April 11, 2023
Via
Benzinga
A Look Into Biogen's Debt
April 03, 2023
Via
Benzinga
Price Over Earnings Overview: Biogen
March 31, 2023
Via
Benzinga
Biogen Unusual Options Activity
March 23, 2023
Via
Benzinga
11 Analysts Have This to Say About Biogen
March 23, 2023
Via
Benzinga
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Via
Benzinga
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
April 10, 2023
Shares are closing in on a buy point out of a consolidation.
Via
Investor's Business Daily
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
April 07, 2023
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
Via
Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
April 03, 2023
Bloomberg UBS Prepping For Massive Layoffs Amid Credit Suisse Takeover
Via
Benzinga
Should You Buy Biogen Before a Big July Decision?
March 19, 2023
Biogen stock has dropped about 40% from its record high.
Via
The Motley Fool
Price Over Earnings Overview: Biogen
March 17, 2023
Via
Benzinga
(BIIB) - Analyzing Biogen's Short Interest
March 17, 2023
Via
Benzinga
Biogen's Debt Overview
March 15, 2023
Via
Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
April 03, 2023
The U.S. National Institute on Aging (NIA), part of the government's National Institutes of Health (NIH), aims to build an Alzheimer's research database. Alzheimer's Association Chief Science Officer...
Via
Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
March 31, 2023
Via
Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.
Via
InvestorPlace
Elliott Wave Technical Analysis: Biogen Inc. - Thursday, March 23
March 23, 2023
Looking for longs after a clear resumption of the uptrend.
Via
Talk Markets
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
March 23, 2023
The companies are focusing on a small population of ALS patients with a genetic mutation.
Via
Investor's Business Daily
1 Reason to Buy Biogen Stock, and 1 Reason to Sell
March 14, 2023
It could be a make or break year for the biotech.
Via
The Motley Fool
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Via
Benzinga
iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach
March 22, 2023
Interested in investing in iMetabolic BioPharma? Click here to get started!
Via
Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio as we get deeper into 2023.
Via
InvestorPlace
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
March 20, 2023
Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days.
Via
Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Via
Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
Via
Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.